Northwestern Mutual Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	2,336 +329	+16%	+$29.6K	﹤0.01%	1937
2026 Q1	$174K	Sell	2,007 -546	-21%	-$47.8K	﹤0.01%	1967
2025 Q4	$217K	Buy	2,553 +567	+29%	+$45.3K	﹤0.01%	1835
2025 Q3	$144K	Buy	1,986 +87	+5%	+$6K	﹤0.01%	1919
2025 Q2	$124K	Sell	1,899 -343	-15%	-$22.3K	﹤0.01%	1928
2025 Q1	$158K	Buy	2,242 +1	+0%	+$69	﹤0.01%	1761
2024 Q4	$147K	Hold	2,241	–	–	﹤0.01%	1776
2024 Q3	$158K	Buy	2,241 +1	+0%	+$70	﹤0.01%	1717
2024 Q2	$149K	Buy	2,240 +16	+0.7%	+$1.05K	﹤0.01%	1669
2024 Q1	$151K	Sell	2,224 -23	-1%	-$1.52K	﹤0.01%	1660
2023 Q4	$139K	Buy	2,247 +42	+2%	+$2.47K	﹤0.01%	1651
2023 Q3	$130K	Sell	2,205 -168	-7%	-$10.3K	﹤0.01%	1609
2023 Q2	$142K	Buy	2,373 +168	+8%	+$9.99K	﹤0.01%	1593
2023 Q1	$129K	Buy	2,205 +3	+0.1%	+$181	﹤0.01%	1598
2022 Q4	$137K	Sell	2,202 -213	-9%	-$12.8K	﹤0.01%	1542
2022 Q3	$136K	Sell	2,415 -180	-7%	-$11.1K	﹤0.01%	1534
2022 Q2	$166K	Sell	2,595 -162	-6%	-$10.3K	﹤0.01%	1450
2022 Q1	$179K	Buy	2,757 +396	+17%	+$25.1K	﹤0.01%	1476
2021 Q4	$157K	Buy	2,361 +90	+4%	+$5.71K	﹤0.01%	1531
2021 Q3	$139K	Buy	2,271 +900	+66%	+$57.2K	﹤0.01%	1488
2021 Q2	$85K	Buy	1,371 +219	+19%	+$13.3K	﹤0.01%	1660
2021 Q1	$68K	Sell	1,152 -30	-3%	-$1.81K	﹤0.01%	1624
2020 Q4	$71K	Hold	1,182	–	–	﹤0.01%	1531
2020 Q3	$64K	Buy	1,182 +9	+0.8%	+$485	﹤0.01%	1421
2020 Q2	$60K	Buy	1,173 +87	+8%	+$4.37K	﹤0.01%	1392
2020 Q1	$49K	Buy	1,086 +336	+45%	+$16.9K	﹤0.01%	1391
2019 Q4	$40K	Buy	750 +510	+213%	+$25.1K	﹤0.01%	1541
2019 Q3	$11K	Hold	240	–	–	﹤0.01%	1899
2019 Q2	$12K	Buy	240 +90	+60%	+$4.45K	﹤0.01%	1899
2019 Q1	$8K	Hold	150	–	–	﹤0.01%	2007
2018 Q4	$7K	Hold	150	–	–	﹤0.01%	1940
2018 Q3	$8K	Hold	150	–	–	﹤0.01%	1984
2018 Q2	$8K	Hold	150	–	–	﹤0.01%	1890
2018 Q1	$7K	Hold	150	–	–	﹤0.01%	1833
2017 Q4	$8K	Sell	150 -195	-57%	-$10K	﹤0.01%	1814
2017 Q3	$18K	Sell	345 -120	-26%	-$6.16K	﹤0.01%	1494
2017 Q2	$24K	Hold	465	–	–	﹤0.01%	1325
2017 Q1	$23K	Sell	465 -384	-45%	-$19K	﹤0.01%	1279
2016 Q4	$40K	Buy	849 +21	+3%	+$996	﹤0.01%	1102
2016 Q3	$41K	Sell	828 -204	-20%	-$10.3K	﹤0.01%	1024
2016 Q2	$50K	Buy	1,032 +204	+25%	+$9.71K	﹤0.01%	904
2016 Q1	$38K	Sell	828 -192	-19%	-$8.98K	﹤0.01%	981
2015 Q4	$55K	Hold	1,020	–	–	﹤0.01%	764
2015 Q3	$50K	Hold	1,020	–	–	﹤0.01%	708
2015 Q2	$59K	Buy	+1,020	New	+$59.6K	﹤0.01%	650

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Northwestern Mutual Wealth Management's IHE Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its iShares US Pharmaceuticals ETF (IHE) stake by 16% in Q2 2026, buying an estimated $29.6K and bringing the position to 2,336 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1937.

Northwestern Mutual Wealth Management first reported a position in IHE in Q2 2015 and has held it in 45 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Northwestern Mutual Wealth Management held 2,336 shares of iShares US Pharmaceuticals ETF worth $231K as of Q2 2026.
Northwestern Mutual Wealth Management bought 329 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $29.6K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1937 holding.
Northwestern Mutual Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and has held it in 45 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.